192 related articles for article (PubMed ID: 28860661)
41. Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.
Li K; Liu Y; Liu C; Gao L; Zhang Y; Cui H; Gao Y; Qi X; Zhong L; Wang X
Sci Rep; 2016 Dec; 6():39263. PubMed ID: 27982090
[TBL] [Abstract][Full Text] [Related]
42. Use of Marek's disease vaccines: could they be driving the virus to increasing virulence?
Davison F; Nair V
Expert Rev Vaccines; 2005 Feb; 4(1):77-88. PubMed ID: 15757475
[TBL] [Abstract][Full Text] [Related]
43. Marek's disease virus EcoRI-Q gene (meq) and a small RNA antisense to ICP4 are abundantly expressed in CD4+ cells and cells carrying a novel lymphoid marker, AV37, in Marek's disease lymphomas.
Ross N; O'Sullivan G; Rothwell C; Smith G; Burgess SC; Rennie M; Lee LF; Davison TF
J Gen Virol; 1997 Sep; 78 ( Pt 9)():2191-8. PubMed ID: 9292006
[TBL] [Abstract][Full Text] [Related]
44. Expression of SC1, a cell adhesion molecule, promotes the metastatic activities of the Gallus gallus lymphoblastoid cell line MDCC-MSB1 derived from Marek's disease.
Handharyani E; Tsukamoto M; Tsukamoto Y
Avian Pathol; 2011 Feb; 40(1):111-5. PubMed ID: 21331955
[TBL] [Abstract][Full Text] [Related]
45. Investigation of Marek's disease virus from chickens in central Ethiopia.
Demeke B; Jenberie S; Tesfaye B; Ayelet G; Yami M; Lamien CE; Gelaye E
Trop Anim Health Prod; 2017 Feb; 49(2):403-408. PubMed ID: 27975190
[TBL] [Abstract][Full Text] [Related]
46. Increased virulence of Marek's disease virus type 1 vaccine strain CV1988 after adaptation to qt35 cells.
Majerciak V; Valkova A; Szabová D; Geerligs H; Zelník V
Acta Virol; 2001 Apr; 45(2):101-8. PubMed ID: 11719980
[TBL] [Abstract][Full Text] [Related]
47. Comparison of exosomes purified via ultracentrifugation (UC) and Total Exosome Isolation (TEI) reagent from the serum of Marek's disease virus (MDV)-vaccinated and tumor-bearing chickens.
Nath Neerukonda S; Egan NA; Patria J; Assakhi I; Tavlarides-Hontz P; Modla S; Muñoz ER; Hudson MB; Parcells MS
J Virol Methods; 2019 Jan; 263():1-9. PubMed ID: 30316797
[TBL] [Abstract][Full Text] [Related]
48. On the specificity of the immunoglobulin G produced by chickens experimentally infected with Marek's disease virus.
Settnes OP
Nord Vet Med; 1985; 37(3):170-5. PubMed ID: 2993996
[TBL] [Abstract][Full Text] [Related]
49. Cytokine gene expression in splenic CD4+ and CD8+ T cell subsets of genetically resistant and susceptible chickens infected with Marek's disease virus.
Parvizi P; Read LR; Abdul-Careem MF; Sarson AJ; Lusty C; Lambourne M; Thanthrige-Don N; Burgess SC; Sharif S
Vet Immunol Immunopathol; 2009 Dec; 132(2-4):209-17. PubMed ID: 19615758
[TBL] [Abstract][Full Text] [Related]
50. Very virulent plus strains of MDV induce an acute form of transient paralysis in both susceptible and resistant chicken lines.
Xu M; Fitzgerald SD; Zhang H; Karcher DM; Heidari M
Viral Immunol; 2012 Aug; 25(4):306-23. PubMed ID: 22803780
[TBL] [Abstract][Full Text] [Related]
51. Host genetic resistance to Marek's disease sustains protective efficacy of herpesvirus of turkey in both experimental and commercial lines of chickens.
Chang S; Xie Q; Dunn JR; Ernst CW; Song J; Zhang H
Vaccine; 2014 Apr; 32(16):1820-7. PubMed ID: 24530405
[TBL] [Abstract][Full Text] [Related]
52. A MEQ-deleted Marek's disease virus cloned as a bacterial artificial chromosome is a highly efficacious vaccine.
Silva RF; Dunn JR; Cheng HH; Niikura M
Avian Dis; 2010 Jun; 54(2):862-9. PubMed ID: 20608531
[TBL] [Abstract][Full Text] [Related]
53. A comparative evaluation of the protective efficacy of rMd5deltaMeq and CVI988/ Rispens against a vv+ strain of Marek's disease virus infection in a series of recombinant congenic strains of White Leghorn chickens.
Chang S; Ding Z; Dunn JR; Lee LF; Heidari M; Song J; Ernst CW; Zhang H
Avian Dis; 2011 Sep; 55(3):384-90. PubMed ID: 22017035
[TBL] [Abstract][Full Text] [Related]
54. Induction of lymphomas and tumor antigen by Marek's disease virus in turkeys.
Elmubarak AK; Sharma JM; Witter RL; Nazerian K; Sanger VL
Avian Dis; 1981; 25(4):911-26. PubMed ID: 6279077
[TBL] [Abstract][Full Text] [Related]
55. Genome-wide mapping of DNase I hypersensitive sites and association analysis with gene expression in MSB1 cells.
He Y; Carrillo JA; Luo J; Ding Y; Tian F; Davidson I; Song J
Front Genet; 2014; 5():308. PubMed ID: 25352859
[TBL] [Abstract][Full Text] [Related]
56. Protective efficacy of a recombinant bacterial artificial chromosome clone of a very virulent Marek's disease virus containing a reticuloendotheliosis virus long terminal repeat.
Mays JK; Black-Pyrkosz A; Spatz S; Fadly AM; Dunn JR
Avian Pathol; 2016 Dec; 45(6):657-666. PubMed ID: 27258614
[TBL] [Abstract][Full Text] [Related]
57. [Experimental induction of the cutaneous form of Marek's disease in broilers].
Halouzka R; Jurajda V
Vet Med (Praha); 1982 Apr; 27(4):217-26. PubMed ID: 6808750
[TBL] [Abstract][Full Text] [Related]
58. Marek's disease in turkeys. II. Characterization of the viral glycoprotein B gene and antigen of a turkey strain of Marek's disease virus.
Davidson I; Malkinson M; Weisman Y
Avian Dis; 2002; 46(2):322-33. PubMed ID: 12061641
[TBL] [Abstract][Full Text] [Related]
59. Transcriptional analysis of host responses to Marek's disease virus infection in genetically resistant and susceptible chickens.
Sarson AJ; Parvizi P; Lepp D; Quinton M; Sharif S
Anim Genet; 2008 Jun; 39(3):232-40. PubMed ID: 18371127
[TBL] [Abstract][Full Text] [Related]
60. Marek's disease virus immunosuppression alters host cellular responses and immune gene expression in the skin of infected chickens.
Heidari M; Wang D; Delekta P; Sun S
Vet Immunol Immunopathol; 2016 Nov; 180():21-28. PubMed ID: 27692091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
